Ken Griffin’s Acumen Pharmaceuticals ABOS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 5757 |
|
|
2025
Q1 | – | Sell |
-9,597
| Closed | -$16.5K | – | 5864 |
|
|
2024
Q4 | $16.5K | Sell |
9,597
-7,315
| -43% | -$12.6K | ﹤0.01% | 5671 |
|
|
2024
Q3 | $41.9K | Sell |
16,912
-66,100
| -80% | -$164K | ﹤0.01% | 5166 |
|
|
2024
Q2 | $201K | Buy |
83,012
+59,661
| +255% | +$144K | ﹤0.01% | 4672 |
|
|
2024
Q1 | $94.6K | Sell |
23,351
-107,765
| -82% | -$436K | ﹤0.01% | 5098 |
|
|
2023
Q4 | $503K | Buy |
131,116
+130,884
| +56,416% | +$503K | ﹤0.01% | 3736 |
|
|
2023
Q3 | $963 | Sell |
232
-47,162
| -100% | -$196K | ﹤0.01% | 5697 |
|
|
2023
Q2 | $228K | Buy |
47,394
+33,313
| +237% | +$160K | ﹤0.01% | 4333 |
|
|
2023
Q1 | $57.2K | Buy |
+14,081
| New | +$57.2K | ﹤0.01% | 5120 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6014 |
|
|
2022
Q3 | – | Sell |
-53,749
| Closed | -$253K | – | 5799 |
|
|
2022
Q2 | $253K | Sell |
53,749
-99,498
| -65% | -$468K | ﹤0.01% | 4780 |
|
|
2022
Q1 | $599K | Buy |
153,247
+78,724
| +106% | +$308K | ﹤0.01% | 4268 |
|
|
2021
Q4 | $504K | Buy |
74,523
+35,177
| +89% | +$238K | ﹤0.01% | 4595 |
|
|
2021
Q3 | $585K | Buy |
+39,346
| New | +$585K | ﹤0.01% | 4357 |
|